Besides, SLC35A2 is highly expressed in advance stages of CRC, and patients with microsatellite stable (MSS) CRC exhibits significantly higher level of SLC35A2 than the patients with microsatellite instable (MSI) CRC (Supplementary Figure 1). This evidence concerns the gene SLC35A2 and colorectal carcinoma.